Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products … Read more
Goodrx Holdings Inc (GDRX) - Total Liabilities
Latest total liabilities as of September 2025: $724.79 Million USD
Based on the latest financial reports, Goodrx Holdings Inc (GDRX) has total liabilities worth $724.79 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Goodrx Holdings Inc - Total Liabilities Trend (2016–2024)
This chart illustrates how Goodrx Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Goodrx Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Goodrx Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MAS Financial Services Limited
NSE:MASFIN
|
India | ₹102.87 Billion |
|
Napatech A/S
OL:NAPA
|
Norway | Nkr59.29 Million |
|
Hawthorn Bancshares Inc
NASDAQ:HWBK
|
USA | $1.72 Billion |
|
Qingdao Victall Railway Co Ltd
SHG:605001
|
China | CN¥2.47 Billion |
|
Suzhou Wanxiang Technology Co. Ltd.
SHE:301180
|
China | CN¥609.82 Million |
|
InfoVision Optoelectronics Kunshan Co Ltd
SHG:688055
|
China | CN¥2.50 Billion |
|
CPH Group AG
F:1L6
|
Germany | €166.65 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Goodrx Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Goodrx Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Goodrx Holdings Inc (2016–2024)
The table below shows the annual total liabilities of Goodrx Holdings Inc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $663.41 Million | -19.77% |
| 2023-12-31 | $826.84 Million | +4.69% |
| 2022-12-31 | $789.80 Million | +1.79% |
| 2021-12-31 | $775.95 Million | -0.93% |
| 2020-12-31 | $783.23 Million | -46.88% |
| 2019-12-31 | $1.47 Billion | -0.19% |
| 2018-12-31 | $1.48 Billion | +986.13% |
| 2017-12-31 | $136.01 Million | +195.16% |
| 2016-12-31 | $46.08 Million | -- |